root
rhizom
licoric
glycyrrhiza
speci
long
use
worldwid
herbal
medicin
natur
sweeten
licoric
root
tradit
medicin
use
mainli
treatment
peptic
ulcer
hepat
c
pulmonari
skin
diseas
although
clinic
experiment
studi
suggest
sever
use
pharmacolog
properti
antiinflammatori
antivir
antimicrobi
antioxid
anticanc
activ
immunomodulatori
hepatoprotect
cardioprotect
effect
larg
number
compon
isol
licoric
includ
triterpen
saponin
flavonoid
isoflavonoid
chalcon
glycyrrhiz
acid
normal
consid
main
biolog
activ
compon
review
summar
phytochem
pharmacolog
pharmacokinet
data
togeth
clinic
advers
effect
licoric
bioactiv
compon
licoric
speci
perenni
herb
nativ
mediterranean
region
central
southern
russia
asia
minor
iran
wide
cultiv
throughout
europ
middl
east
asia
blumenth
et
al
use
medic
sinc
least
bc
licoric
describ
grandfath
herb
odi
genu
glycyrrhiza
leguminosa
consist
speci
includ
g
glabra
g
uralensi
g
inflata
g
aspera
g
korshinskyi
g
eurycarpa
g
glabra
also
includ
three
varieti
persian
turkish
licoric
assign
g
glabra
var
violacea
russian
licoric
g
glabra
var
gladulifera
spanish
italian
licoric
g
glabra
var
typica
nomura
et
al
also
known
liquoric
kanzoh
gancao
sweet
root
yastimadhu
blumenth
et
al
nomura
et
al
licoric
root
contain
triterpenoid
saponin
mostli
glycyrrhizin
mixtur
potassium
calcium
salt
glycyrrhiz
acid
also
known
glycyrrhiz
glycyrrhizin
acid
glycosid
glycyrrhetin
acid
time
sweet
sugar
blumenth
et
al
antiinflammatori
activ
acid
shown
antiinflammatori
properti
differ
anim
model
capasso
et
al
amagaya
et
al
inou
et
al
acid
major
metabolit
glycyrrhizin
gumpricht
et
al
two
mechan
suggest
antiinflammatori
effect
acid
first
inhibit
glucocorticoid
metabol
potenti
effect
potenti
report
skin
lung
coadministr
acid
teelucksingh
et
al
schleimer
sinc
acid
potent
inhibitor
hydroxygenas
walker
edward
caus
accumul
glucocorticoid
antiinflammatori
properti
oral
administr
acid
glycyrrhizin
confirm
result
mackenzi
et
al
second
inhibit
classic
complement
pathway
activ
activ
depend
conform
kroe
et
al
thu
suggest
comed
hydrocortison
treatment
inflammatori
lung
diseas
use
schleimer
glycyrrhizin
inhibit
reactiv
oxygen
speci
ro
gener
neutrophil
potent
mediat
tissu
inflamm
vitro
studi
thought
one
antiinflammatori
effect
due
inhibitori
effect
akamatsu
et
al
wang
nixon
also
gener
reactiv
oxygen
speci
also
suppress
glabridin
treatment
raw
cell
jong
et
al
g
glabra
glyderinin
deriv
glycyrrhiz
acid
show
antiinflammatori
effect
azimov
et
al
tokiwa
et
al
also
reduc
myocardi
inflammatori
edema
experiment
myocardi
damag
zakirov
et
al
addit
glabridin
lichochalocon
shown
antiinflammatori
effect
vivo
studi
jong
et
al
glycyrrhetin
acid
inhibit
either
cyclooxygenas
catalys
prostaglandin
biosynthesi
ic
valu
vitro
studi
perera
et
al
howev
anoth
studi
g
radix
believ
involv
inhibit
kase
et
al
furthermor
paper
g
radix
increas
corticosteron
level
rat
also
glycyrrhizin
glycyrrhetin
acid
known
inhibit
phospholipas
kase
et
al
recent
deriv
glycyrrhetin
acid
shown
inhibitori
activ
induc
prostaglandin
product
normal
human
dermal
fibroblast
nhdf
tsukahara
et
al
methanol
extract
aerial
part
g
glabra
show
antibacteri
activ
sever
kind
bacteria
sabahi
et
al
sever
flavonoid
aliphat
residu
isol
effect
constitu
licoric
methicillinresist
staphylococcu
aureu
mrsa
restor
effect
oxacillin
antibiot
mrsa
hatano
et
al
hatano
et
al
glabridin
glabren
licochalcon
exhibit
antimicrobi
activ
helicobact
pylori
vitro
fukai
et
al
fukai
et
al
etherwat
extract
g
glabra
found
effect
antibacteri
activ
five
bacteria
e
coli
b
subtili
e
aerogen
k
pneumonia
aureu
onkarappa
et
al
glycyrrhizol
root
g
uralensi
exhibit
potent
antibacteri
activ
streptococcu
mutan
minimum
inhibitori
concentr
respect
et
al
glycyrrhiz
acid
inhibit
replic
sever
virus
vitro
tabl
mechan
found
antivir
effect
glycyrrhizin
van
rossum
et
al
cohen
anoth
studi
glycyrrhiz
acid
induc
apoptosi
primari
effus
lymphoma
pel
cell
transform
kaposi
sarcomaassoci
herpesviru
kshv
termin
latent
infect
b
lymphocyt
curr
et
al
two
coumarin
g
glabra
glycocoumarin
licopyranocoumarin
abl
inhibit
giant
cell
format
hivinfect
cell
cultur
without
cytotox
hatano
et
al
de
simon
et
al
fig
takahara
et
al
sato
et
hepat
c
viru
hcv
van
rossum
et
al
human
cytomegaloviru
cmv
numazaki
et
al
human
immunodefici
viru
hiv
ito
et
al
influenza
viru
utsunomiya
et
al
sar
coronaviru
cinatl
et
al
varicella
zoster
viru
vzv
baba
shigeta
figur
antihiv
coumarin
isol
g
glabra
edefici
e
mice
caus
signific
reduct
ldl
oxid
also
develop
atherosclerot
lesion
fuhrman
et
al
rosenblat
et
al
seem
glabridin
may
possess
properti
two
mechan
first
bind
ldl
substanti
protect
oxid
fuhrman
et
al
belinki
et
al
hydroxyl
group
b
ring
glabridin
found
import
antioxid
properti
belinki
et
al
second
accumul
cell
macrophag
caus
reduct
cellular
oxid
stress
reduc
nadph
oxidas
activ
increas
cellular
glutathion
gsh
rosenblat
et
al
rosenblat
et
al
addit
constitu
g
glabra
isoflavon
hispaglabridin
hispaglabridin
b
two
chalcon
isoprenylchalcon
deriv
isoliquiritigenin
antioxid
ldl
oxid
vitro
studi
glycyrrhizin
hepatoprotect
probabl
prevent
chang
cell
membran
permeabl
nakamura
et
al
nevertheless
suggest
glycyrrheitin
acid
better
hepatoprotect
drug
glycyrrhizin
vitro
studi
nose
et
al
observ
keep
protect
effect
glycyrrhetin
acid
carbon
tetrachlorideinduc
hepatotox
retrorsineinduc
liver
damag
respect
mice
rat
lin
et
al
furthermor
hepatocyt
model
cholestat
liver
injuri
glycyrrhizin
exhibit
proapoptot
properti
wherea
glycyrrheitin
acid
potent
inhibitor
bile
acidinduc
apoptosi
necrosi
gumpricht
et
al
hepatoprotect
effect
glycyrrhizin
summar
tabl
aqueou
extract
g
glabra
inhibit
vivo
vitro
prolifer
ehrlich
ascit
tumor
cell
inhibit
angiogenesi
vivo
assay
periton
chorioallanto
membran
assay
sheela
et
al
also
ethanol
extract
g
uralensi
root
induc
apoptosi
cell
cycl
arrest
human
breast
cancer
cell
jo
et
al
hand
mani
studi
anticanc
effect
sever
deriv
compon
chines
licoric
root
obtain
three
speci
glycyrrhiza
genu
g
glabra
g
uralensi
g
inflata
found
potenti
inhibit
growth
plasmodium
falciparum
leishmania
donovani
vitro
studi
christensen
et
al
christensen
kharazmi
chalcon
licochalcon
chines
licoric
root
known
possess
antiplasmodi
activ
ic
valu
mgml
chen
et
al
jenettsiem
et
al
also
chalcon
potent
antileishmani
activ
might
develop
new
class
antileishmani
drug
chen
et
al
chen
found
chalcon
lichochalcon
alter
ultrastructur
parasit
mitochondria
inhibit
function
select
inhibit
fumar
reductas
frd
respiratori
chain
parasit
zhai
et
al
chen
et
al
constitu
g
inflata
licochalcon
b
c
echinatin
effect
prevent
microsom
lipid
peroxid
induc
fe
iii
adpnadph
licochalcon
b
show
potent
antioxid
superoxid
scaveng
activ
haraguchi
et
al
furthermor
isoflavon
deriv
g
glabra
glabridin
inhibit
lipid
peroxid
rat
liver
microsom
protect
mitochondri
function
oxid
stress
haraguchi
et
al
hispaglabridin
especi
show
potent
antioxid
activ
peroxid
induc
feascorb
haraguchi
moreov
glabridin
isoflavan
g
glabra
potent
antioxid
toward
ldl
oxid
vitro
vivo
studi
fuhrman
et
al
vaya
et
al
belinki
et
al
consumpt
licoric
glabridin
atherosclerot
apolipoprotein
copyright
shiki
et
al
deceas
ldh
glutam
oxaloacet
transaminas
nakamura
et
al
increas
surviv
rate
hepatocyt
cultur
nacagiri
et
al
suppress
elev
lipid
peroxid
ast
alt
ldh
decreas
morpholog
damag
nagai
et
al
normal
serum
level
transaminas
lin
et
al
normal
serum
aminotransferas
alkalin
phosphatas
bilirubin
asgari
et
al
method
incub
antiliv
cell
membran
antibodi
complement
ccl
induc
hepatotox
acetaminophen
dgalactosamin
induc
liver
injuri
ischemiareperfus
damag
thioacethamideinduc
liver
damag
vivo
vitro
studi
detail
see
tabl
glycyrrhetin
acid
could
also
trigger
proapoptot
pathway
induc
mitochondri
permeabl
transit
properti
may
use
induc
apoptosi
tumor
cell
salvi
et
al
fior
et
al
recent
licochalcon
e
new
retrochalcon
root
g
inflata
exhibit
potent
cytotox
effect
compar
known
antitumor
agent
licochalcon
isoliquiritigenin
yoon
et
al
glabridin
inhibit
serotonin
reuptak
ofir
et
al
addit
recent
aqueou
extract
g
glabra
l
show
antidepress
activ
forc
swim
test
fst
tail
suspens
test
tst
mice
dhingra
sharma
ethanol
extract
g
glabra
anticonvuls
effect
ptz
lithiumpilocarpineinduc
convuls
model
ambawad
et
al
also
aqueou
extract
g
glabra
show
memori
enhanc
effect
plusmaz
passiv
avoid
paradigm
dhingra
et
al
moreov
chronic
administr
extract
g
glabra
low
high
dose
induc
correct
passiv
avoid
perform
ovariectom
femal
rat
fedotova
et
al
combin
treatment
licoric
root
vibrat
result
increas
succin
dehydrogenas
sdh
activ
differ
part
brain
improv
brain
energi
suppli
amelior
effect
vibrat
oganisyan
et
al
addit
isoliquiritigenin
show
protect
effect
cerebr
ischemiareperfus
injuri
rat
zhan
yang
carbenoxolon
shown
anticonvuls
sed
muscl
relax
activ
mice
genet
epilepsi
prone
rat
gepr
hosseinzadeh
nassiri
asl
gareri
et
al
also
abl
suppress
gener
superoxid
anion
hydrogen
peroxid
macrophag
also
show
protect
effect
skelet
muscl
hippocampu
acut
ischemicreperfus
effect
rat
suzuki
et
al
hosseinzadeh
et
al
addit
could
decreas
learn
perform
rat
spatial
memori
task
hosseinzadeh
et
al
licoric
show
antiplatelet
aggreg
effect
tawata
et
al
yu
et
al
experi
glycyrrhizin
identifi
thrombin
inhibitor
vitro
vivo
studi
believ
glycyrrhizin
might
use
model
search
new
antithrombot
drug
francischetti
et
al
mendessilva
et
al
also
g
glabra
acceler
metabol
cell
bone
marrow
erythroid
stem
increas
anim
resist
stress
adamyan
et
al
isoliquiritigenin
activ
compon
licoric
report
vasorelax
effect
yu
kuo
could
also
abl
decreas
tube
format
vascular
endotheli
cell
thu
antiangiogen
effect
licoric
extract
depend
antitub
format
effect
isoliquiritin
kobayashi
et
al
hand
estrogenlik
activ
glabridin
vivo
vitro
studi
demonstr
could
modul
vascular
injuri
atherogenesi
therefor
suggest
prevent
cardiovascular
diseas
postmenopaus
women
somjen
et
al
sever
immunomodulatori
activ
attribut
glycyrrhizin
glycyrrhetin
acid
ohuchi
et
al
kobayashi
et
al
zhang
et
al
kondo
takano
raphael
kuttan
result
seen
lichochalchon
analogu
show
immunomodulatori
effect
barfod
et
al
hand
glycyrrhizin
select
activ
extrathym
cell
liver
human
cell
copyright
antitumor
activ
induc
apoptosi
modul
protein
express
rafi
et
al
rafi
et
al
fu
et
al
antitumor
promot
activ
prevent
tpa
bind
membran
receptor
kitagawa
et
al
shibata
et
al
inhibitori
effect
shibata
et
al
antitumorpromot
activ
kitagawa
et
al
protect
effect
prevent
chemicalinduc
carcinogen
inhibit
activ
hepatotox
metabolit
chan
et
al
inhibit
induct
acf
colon
carcinoma
develop
baba
et
al
takahashi
et
al
inhibit
epiderm
odc
suppress
dmba
effect
yamamoto
et
al
induc
cell
death
promot
bax
express
iwashita
et
al
antiprolif
activ
et
al
antiprolif
activ
maggiolini
et
al
antiprolif
activ
kanazawa
et
al
inhibit
cell
growth
decreas
cell
number
induc
apoptosi
jung
et
al
antiprolif
activ
enhanc
express
express
hsu
et
al
ii
et
al
reduc
pulmonari
metastasi
yamazaki
et
al
induc
apoptot
cell
death
inhibit
nfkappab
survivalsign
pathway
hsu
et
al
antiprolif
effect
tamir
et
al
inhibit
format
prolifer
total
dmbadna
adduct
mammari
gland
lin
et
al
cytostat
effect
deregul
cell
cycl
jackson
et
al
method
breast
leukemia
prostat
cancer
cell
line
ishiwata
et
al
glycyrrhizin
also
improv
impair
resist
thermal
injur
mice
herp
viru
infect
utsunomiya
et
al
moreov
glycyrrhetin
acid
induc
type
antagonist
cell
vivo
vitro
studi
kobayashi
et
al
utsunomiya
et
al
nakajima
et
al
improv
resist
mice
infect
murin
leukemia
viru
maid
mice
candida
albican
infect
utsunomiya
et
al
also
stimul
macrophagederiv
product
abl
upregul
ino
express
nuclear
factor
kb
nfkb
transactiv
murin
macrophag
jeong
kim
could
induc
interferon
activ
augment
natur
killer
cell
activ
studi
glycyrrhizin
superior
glycyrrhetin
acid
induc
interferon
abe
et
al
also
inhibitori
effect
tnfalphainduc
product
intestin
epitheli
cell
kang
et
al
addit
studi
immunomodulatori
effect
polysaccharid
fraction
obtain
shoot
g
glabra
hairi
root
g
uralensi
vitro
nose
et
al
two
isol
acid
polysaccharid
g
uralensi
shown
anticomplementari
activ
also
anticomplementari
activ
mitogen
activ
zhao
et
al
yamada
et
al
kiyohara
et
al
recent
haemolyt
activ
g
uralensi
saponin
gl
adjuv
potenti
ovalbumin
ova
establish
mice
sun
pan
glabridin
show
antinephr
effect
mous
glomerular
diseas
model
fukai
et
al
also
glycyrrhizin
could
amelior
renal
defect
gentamicininduc
acut
renal
failur
rat
sohn
et
al
also
extract
g
radix
could
protect
kidney
peroxynitrit
onoo
induc
oxid
stress
copyright
vivo
scaveng
onoo
andor
precursor
yokozawa
et
al
sixti
nine
compound
glycyrrhiza
phenol
show
inhibitori
activ
growth
bacillu
subtili
isoliquiritigenin
posit
recassay
fukai
et
al
recent
one
studi
g
radix
produc
persist
antituss
effect
guineapig
suggest
liquiritin
apiosid
main
antituss
compon
play
import
role
earlier
phase
liquiritigenin
liquiritin
play
import
role
late
phase
kamei
et
al
result
keep
previou
antituss
effect
licoric
glycyrrhitin
acid
deriv
shown
inhibit
gap
junction
channel
davidson
baumgarten
inhibitori
effect
acid
gap
junction
channel
arteriolar
smooth
muscl
endotheli
cell
renal
pelvi
uret
mesenter
small
arteri
studi
santicioli
maggi
matchkov
et
al
effect
licoric
endocrin
system
vitro
vivo
studi
summar
tabl
seem
herb
act
metabol
steroid
differ
mechan
endocrinolog
studi
glabridin
increas
growth
mous
osteoblast
human
cell
line
somjen
et
al
choi
alcohol
extract
licoric
reduc
glucos
level
genet
diabet
kka
mice
kuroda
et
al
addit
dermatolog
studi
show
three
flavonoid
licoric
licurasid
isoliquiritin
licochalcon
high
potenti
studi
depig
agent
inhibit
tyrosinas
fu
et
al
result
report
glycyrrhisoflavon
glyasperin
c
kim
et
al
shown
oral
licoric
combin
product
could
heal
ulcer
effect
blocker
kassir
ali
et
al
glycyrrhizin
acid
major
compon
licoric
antiulc
properti
seem
rais
local
concentr
prostaglandin
promot
mucou
secret
cell
prolifer
stomach
lead
heal
ulcer
experiment
studi
van
marl
et
al
baker
carbenoxolon
hemisuccin
deriv
acid
enoxolon
two
chemic
synthet
deriv
licoric
use
clinic
therapi
fig
enoxolon
analogu
carbenoxolon
use
treatment
peptic
ulcer
diseas
git
disord
skin
disord
mouth
throat
disord
sweetman
carbenoxolon
use
peptic
ulcer
diseas
gastrooesophag
reflux
also
use
symptomat
manag
mouth
ulcer
gel
mouthwash
sweetman
licoric
root
identifi
nation
cancer
institut
possess
cancerprevent
properti
craig
wang
nixon
use
among
patient
prostat
cancer
ingredi
pcspe
commerci
avail
combin
eight
herb
dipaola
et
al
g
glabra
extract
show
great
antioxid
free
radic
scaveng
activ
topic
formul
may
use
topic
formul
order
protect
skin
damag
caus
free
radic
reactiv
oxygen
speci
di
mambro
fonseca
world
especi
asia
glycyrrhiz
acid
use
intraven
treatment
chronic
hepat
b
c
prepar
name
stronger
neominophagen
c
snmc
decreas
aminotransferas
level
patient
chronic
hepat
multipl
doubleblind
studi
van
rossum
et
al
iino
et
al
zhang
wang
suggest
glycyrrhizin
prevent
effect
develop
hepatocellular
carcinoma
hcc
patient
hcvassoci
chronic
hepat
aras
et
al
miyakawa
iino
licoric
report
direct
hepatoprotect
effect
luper
leung
et
al
glycyrrhizin
major
compon
often
use
treat
patient
chronic
liver
damag
receiv
respond
interferon
ifn
therapi
okuno
et
al
stronger
neominophagen
c
snmc
contain
mgml
glycyrrhizin
use
clinic
antihepat
agent
shibata
g
glabra
l
use
herbal
medicin
skin
erupt
includ
dermat
eczema
pruritu
cyst
saeedi
et
al
section
variou
studi
licoric
skin
summar
tabl
recent
glycyrrhizin
treatment
show
protect
effect
uvbirradi
human
melanoma
cell
rossi
et
al
moreov
licoric
extract
activ
compon
glycyrrhiz
acid
describ
effect
skin
whiten
effect
smith
group
briganti
classifi
liquiritin
skin
turnov
acceler
briganti
et
al
howev
suggest
liquiritin
caus
depigment
two
mechan
first
via
melanin
dispers
mean
pyran
ring
flavonoid
nucleu
second
acceler
epiderm
renew
amer
metwal
concern
mechan
glabridin
melanogenesi
inflamm
shown
inhibit
tyrosinas
activ
melanocyt
result
seem
hydroquinon
replac
licoric
extract
new
prepar
dermal
melasma
piamphongs
howev
case
allerg
dermat
develop
oil
solubl
licoric
extract
nishioka
seguchi
glycyrrhiza
root
shown
decreas
circul
level
testosteron
men
women
armanini
et
al
armanini
et
al
rafi
et
al
armanini
et
al
abl
reduc
salivari
testosteron
men
significantli
joseph
et
al
moreov
induc
regular
ovul
pregnanc
infertil
hyperandrogen
patient
yaginuma
et
al
hand
isoliquiritigenin
ilc
glabren
glabridin
phytoestrogen
ilc
glabren
bind
human
estrogen
receptor
er
higher
affin
glabridin
suggest
isoflaven
may
serv
natur
estrogen
agonist
prevent
symptom
diseas
associ
estrogen
defici
tamir
et
al
tamir
et
al
tradit
chines
medicin
prepar
root
g
glabra
use
treatment
menopauserel
symptom
clinic
data
regard
safeti
efficaci
treat
hot
flash
santoro
et
al
moreov
activ
potent
block
vivo
vitro
glycyrrhetin
acid
two
mechan
direct
competit
inhibit
pretransl
inhibit
ferrari
et
al
seem
herb
act
metabol
steroid
differ
mechan
consumpt
licoric
extract
glycyrrhetin
acid
could
decreas
bodi
fat
mass
human
possibl
mechan
seem
inhibit
level
fat
cell
armanini
et
al
licoric
use
coughreliev
medicin
herb
ancient
time
seem
mucilag
present
secret
produc
influenc
activ
substanc
cover
oral
throat
mucosa
sooth
irrit
reliev
dri
cough
odi
puodziunien
et
al
ammonium
glycyrrhiz
licoric
root
use
toothpast
mouth
rins
product
control
periodont
diseas
goldi
extract
g
glabra
combin
herb
immunoguard
effect
prophylact
manag
treatment
patient
famili
mediterranean
fever
fmf
amaryan
et
al
commerci
licoric
ad
chew
gum
chocol
candi
cigarett
smoke
mixtur
chew
tobacco
snuff
sweeten
agent
tyler
et
al
de
klerk
et
al
depigment
melanogenesi
inflamm
yokota
et
al
petit
pierard
halder
richard
glycyrrhetin
acid
ga
dobbin
saul
fraunfeld
cardiovascular
torsad
de
point
eriiksson
et
al
tachycardia
cardiac
arrest
bannist
et
al
hypertens
olukoga
donaldson
edema
de
groot
et
al
shibata
endocrin
hypokalemia
nielsen
pedersen
olukoga
davidson
bernardi
et
al
agent
cosmet
nomura
et
al
also
licoric
frequent
employ
mask
tast
bitter
drug
alo
quinin
other
surfact
properti
saponin
may
also
facilit
absorpt
poorli
absorb
drug
anthraquinon
glycosid
tyler
et
al
product
glycyrrhizin
acid
summar
tabl
de
klerk
et
al
larg
amount
licoric
may
result
sever
hypertens
hypokalemia
sign
mineralocorticoid
excess
hypertens
caus
decreas
activ
enzym
respons
renal
convers
cortisol
cortison
thu
licoric
lead
activ
renal
mineralocorticoid
receptor
cortisol
result
state
appar
mineralocorticoid
excess
suppress
rennin
angiotensin
system
conn
et
al
stewart
et
al
van
uum
side
effect
due
consumpt
licoric
report
differ
group
summar
tabl
carmin
et
al
report
ad
licoric
extract
cigarett
tobacco
level
glycyrrhiz
acid
significantli
alter
toxic
smoke
also
paper
mention
licoric
teratogen
genotox
carmin
et
al
anoth
studi
toxic
licoric
extract
shown
liver
black
molli
fish
radhakrishnan
et
al
oral
administr
glycyrrhizin
metabol
glycyrrhetin
acid
intestin
bacteria
contain
hattori
et
al
furthermor
intraven
administ
glycyrrhizin
metabol
liver
lysosom
glycyrrhetin
acid
metabolit
excret
bile
intestin
metabol
bacteria
glycyrrhetin
acid
reabsorb
akao
et
al
fig
dose
kcl
supplement
week
necessari
long
halflif
glycyrrhet
acid
van
den
bosch
et
al
anoth
studi
liquiritin
apiosid
show
peak
plasma
concentr
min
administr
guineapig
gradual
decreas
almost
undetect
h
administr
liquiritigenin
aglycon
liquiritin
apiosid
appear
plasma
h
administr
liquiritin
apiosid
remain
h
administr
plasma
concentr
unchang
liquiritigenin
observ
min
administr
gradual
increas
h
administr
kamei
et
al
glycyrrhizin
genistein
glycyrrhisoflavon
glicoricon
licofuranon
licopyranocoumarin
licocoumaron
licoric
constitu
found
inhibit
monoamin
oxidas
mao
vitro
hatano
et
al
howev
clinic
signific
known
compound
found
speci
base
phenol
constitu
licoric
sp
classifi
three
type
b
c
type
root
rhizom
g
uralensi
contain
licopyranocoumarin
glycycoumarin
andor
licocoumaron
found
g
glabra
g
inflata
type
b
g
glabra
contain
glabridin
glabren
found
sampl
two
speci
type
c
g
inflata
contain
licochalcon
b
found
two
speci
extract
licoric
specimen
type
b
c
inhibit
xanthin
oxidas
activ
extract
licoric
specimen
type
b
also
show
inhibitori
effect
monoamin
oxidas
hatano
et
al
extract
g
uralensi
show
potent
inhibitori
activ
hu
et
al
budzinski
et
al
tsukamoto
et
al
bioassay
purif
compon
vestitol
apioglucosid
liquiritigenin
liquiritin
apiosid
show
potent
inhibitori
activ
among
tsukamoto
et
al
glabridin
also
found
inactiv
enzymat
activ
cyp
competit
inhibit
kent
et
al
hand
prolong
intak
high
le
g
dose
may
result
acceler
metabol
coadminist
drug
daili
oral
dose
le
g
consecut
day
mice
abl
significantli
induc
hepat
lesser
extent
activ
well
mainli
associ
hydroxylas
th
activ
thu
induct
cytochrom
activ
longterm
ingest
licoric
may
clinic
consequ
patient
take
drug
metabol
cyp
enzym
paolini
et
al
high
dose
le
g
could
caus
signific
advers
effect
thu
seem
routin
licoric
consum
induct
might
therefor
predispos
associ
compon
extract
could
affect
pharmacokinet
glycyrrhizin
g
glycyrrhet
acid
ga
main
metabolit
g
administr
aqueou
licoric
root
extract
le
rat
human
g
ga
level
lower
compar
g
alon
pharmacokinet
curv
show
signific
differ
area
plasmatim
curv
auc
c
max
max
paramet
also
data
obtain
urin
sampl
confirm
reduc
bioavail
g
present
le
compar
pure
g
interact
g
constitu
compon
le
intestin
absorpt
mention
thu
modifi
bioavail
could
explain
variou
clinic
advers
effect
result
chronic
oral
administr
g
alon
oppos
le
cantelliforti
et
al
howev
seem
pharmacokinet
differ
speci
anoth
studi
auc
g
ga
oral
administr
le
significantli
higher
pure
g
rabbit
bioavail
g
ga
significantli
better
licoric
pure
g
rabbit
presystem
metabol
pure
g
rabbit
rather
differ
rat
pig
human
hou
et
al
shown
pharmacokinet
g
nonlinear
bolu
intraven
administr
dose
mgkg
rat
declin
concentr
g
plasma
gener
biexponenti
dose
termin
disposit
becam
much
slower
dose
increas
addit
appar
total
bodi
clearanc
decreas
significantli
increas
dose
appar
distribut
volum
intraven
administr
unaffect
dose
tsai
et
al
administr
differ
oral
dose
acid
healthi
volunt
show
biphas
decay
plasma
concentrationtim
curv
dose
mg
peak
plasma
concentr
auc
increas
increas
dose
urinari
elimin
glucuronid
h
less
dose
administ
data
base
singl
dose
kinet
analysi
reveal
multipl
dose
g
betahydroxysteroid
dehydrogenas
betahsd
might
constantli
inhibit
wherea
daili
dose
mg
less
inhibit
might
occur
transient
krahenbuhl
et
al
administr
intraven
g
anim
model
liver
diseas
dgalactosamineintox
gal
rat
significantli
decreas
appar
volum
distribut
v
dss
total
bodi
clearanc
cl
total
normal
rat
g
administ
oral
auc
mean
resid
time
mrt
time
reach
maximum
plasma
concentr
max
g
higher
maximum
plasma
concentr
c
pmax
gal
rat
lower
normal
rat
bioavail
g
significantli
chang
also
auc
ga
oral
administr
g
higher
gal
rat
normal
rat
although
signific
differ
mrt
max
c
pmax
bioavail
ga
gal
normal
rat
howev
chang
absorpt
rate
reduct
hepat
elimin
rate
gal
rat
could
explain
differ
wang
et
al
ga
larg
volum
distribut
long
biolog
halflif
undergo
substanti
enterohepat
circul
tyler
et
al
g
uralensi
rat
mu
et
al
acetaminophen
increas
excret
acetaminophenglucoronid
conjug
rat
moon
kim
prednisolon
decreas
cl
increas
auc
cp
prednisolon
chen
et
al
ga
hydrocortison
increas
effect
hydrocortison
mice
teelucksingh
et
al
ga
oral
contracept
hypertens
edema
hypokalemia
increas
sensit
glycyrrhizin
sensit
advers
effect
women
men
bernardi
et
al
de
klerk
et
al
clearanc
cl
area
curv
auc
plasma
concentr
cp
glycyrrhetin
acid
ga
advers
effect
furthermor
consumpt
licoric
contraind
pregnanc
patient
liver
disord
hypokalemia
like
take
cardiac
glycosid
aldosteron
effect
licoric
root
may
counteract
antihypertens
action
prescrib
medic
cassileth
barazzuol
recent
direct
interact
glycyrrhetin
acid
absorpt
sennosid
deriv
studi
human
mizuhara
et
al
drug
interact
licoric
report
summar
tabl
summari
licoric
use
throughout
world
tradit
herbal
remedi
properti
licoric
activ
constitu
suggest
potenti
role
evalu
effect
treatment
differ
kind
diseas
cancer
atherosclerosi
immunodefici
hormon
defici
endocrin
skin
diseas
howev
necessari
carri
studi
confirm
effect
